This Azim Premji-Backed Large Cap Stock Is Gaining On US FDA Drug Approval
Pharma Giant Cipla Explores Billion-Dollar Stake Sale To Blackstone, Baring Asia: Report
Cipla Recalls Six Batches Of Inhaler In The US Over Container Defect
PharmEasy Parent Set To Secure Significant Funding Amid Debt Challenges
Health Care Recent News
Cyberattack Hits Paracetamol Maker's Revenue And Profit, Shares Fall
|
Toxic Ingredients In Marion Biotech's Cough Syrups May Have Led To Tragedy In Uzbekistan
|
Why This Ashish Dhawan-Backed Pharma Stock Is Tanking Today
|
Lenskart Gets Eye-Catching $100M Funding Boost From ChrysCapital
|
Bill Gates Heaps Praises On PM Modi For Mann Ki Baat: 'Has Catalyzed Community Led Action'
|
Essential Medicines' Prices To Rise By 12%: What's Forcing The Record Hike?
|